Guidance on the licensing of biosimilar products

Information

Type

Guidance

Regulated products

Medical Devices

Topics

Health And Social Care

Published

May 6, 2021

Last updated

November 7, 2022

Description

This guideline is to provide developers of biosimilar products with a clear outline of the requirements in Great Britain.

Organization

Country / Region

United Kingdom

License

Open Government Licence 2.0 (United Kingdom)

Feedback

Suggest an improvement to this page

Actions

Social networks

Embed